Evidence map›Paper›PMID 41951279›Full record

GuidelineJHEP reports : innovation in hepatology2026

EASL position paper on palliative care in advanced chronic liver disease.

Sumita Verma, Matthias Pinter, Lucia Macken, Patrizia Künzler-Heule, Lise Lotte Gluud, Bart Takkenberg, Rui Nunes, Liana Gheorghe, Wendy Prentice, Ben Hudson

Abstract readPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in JHEP reports : innovation in hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sumita VermaDepartment of Clinical and Experimental Medicine, Brighton & Sussex Medical School, University of Brighton and University of Sussex, Brighton, UK; Department of Gastroenterology and Hepatology (Digestive Diseases), University Hospitals Sussex NHS Foundation Trust, Royal Sussex County Hospital, Brighton, UK. Electronic address: s.verma@bsms.ac.uk.
Matthias PinterDivision of Gastroenterology & Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Lucia MackenDepartment of Clinical and Experimental Medicine, Brighton & Sussex Medical School, University of Brighton and University of Sussex, Brighton, UK; Department of Gastroenterology and Hepatology (Digestive Diseases), University Hospitals Sussex NHS Foundation Trust, Royal Sussex County Hospital, Brighton, UK.
Patrizia Künzler-HeuleDepartment of Nursing and Therapeutic Services, Hoch Health Ostschweiz Cantonal Hospital St.Gallen, St.Gallen, Switzerland; Institute of Nursing Science, Department Public Health, Faculty of Medicine, University of Basel, Switzerland.
Lise Lotte GluudGastro Unit, Copenhagen University Hospital Hvidovre, Hvidovre and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Bart TakkenbergAmsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands.
Rui NunesFaculty of Medicine of the University of Porto, Portugal.
Liana GheorgheCarol Davila University of Medicine and Pharmacy, Bucharest, Romania; Center for Digestive Diseases and Liver Transplant, Fundeni Clinical Institute, Bucharest, Romania; Center of Excellence in Translational Medicine, Fundeni Clinical Institute, Bucharest, Romania.
Wendy PrenticeCicely Saunders Institute of Palliative Care, Policy and Rehabilitation, London, UK; Department of Palliative care, Institute of Live Studies, Kings College Hospital NHS Foundation Trust, London, UK.
Ben HudsonDepartment of Gastroenterology and Hepatology, Royal Devon University Healthcare NHS Foundation Trust, Devon, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deaths from advanced chronic liver disease have increased significantly across Europe, with most affected patients not receiving a liver transplant. Despite this increasing burden, inequities in the provision of palliative care persist. Many patients are referred to specialist palliative care only in the final days or weeks of life and may continue to undergo futile invasive procedures. Drawing on the best available evidence, this position paper offers guidance to clinicians on the provision of palliative care to patients with advanced chronic liver disease, with the aim of improving the quality of life of this vulnerable cohort.

Identifiers

PMID41951279
PMCPMC13069526

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.